RecruitingNot ApplicableNCT05985473

Real-time Artificial Intelligence-based Speech Enhancement Methods for Hearing Aid Improvement


Sponsor

Institut Pasteur

Enrollment

40 participants

Start Date

Mar 6, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Individuals with Auditory Neuropathy Spectrum Disorders (ANSD) represent 1-10% of adults with hearing loss. These individuals have little or no benefit from current hearing aids because ANSD is a continuum of hearing impairments due to synaptic or neural dysfunction in the peripheral and central parts of the auditory pathways, which impairs temporal information processing without necessarily affecting auditory sensitivity. There is a need to find ad-hoc denoising methods, based on the expert knowledge of audiologists, to improve the noise comprehension performance of these patients. Implemented denoising methods, based on artificial intelligence, will also greatly benefit more standard hearing loss cases.


Eligibility

Min Age: 18 Years

Inclusion Criteria10

  • For all participants:
  • Age greater than or equal to 18 years,
  • French mother tongue,
  • Have an average tonal hearing loss (calculated according to the BIAP method) < 30 dB HL, on headphones, for each ear,
  • Be professionally active, not be pre-retired and not be unemployed
  • Be affiliated with a social security plan,
  • For participants with TSNA:
  • \- Have degraded comprehension in noise (threshold of Intelligibility in Noise > 3 dB compared to the norm).
  • For controls:
  • \- Have normal comprehension in noise (Intelligibility in Noise threshold ≤ 3 dB from the norm).

Exclusion Criteria6

  • For all participants:
  • Have a conductive or mixed hearing loss, which is when the hearing loss affects both the outer and/or middle ear and the inner ear.
  • Have an asymmetric hearing loss, i.e. a difference in average hearing loss between the left and right ear greater than 30 dB,
  • Have sequelae of ear infections and/or a history of ENT disease that permanently affects hearing (vestibular schwannoma, Meniere's disease, sudden or fluctuating deafness, congenital hypoacusis)
  • Being under guardianship,
  • Being deprived of liberty by judicial or administrative decision, or being subject to legal protection.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERaudiological measurements

audiological measurements

OTHERObjective and subjective audiological measurements

Objective and subjective audiological measurements

OTHEREvaluation of the denoising methods REFINED

Evaluation of the denoising methods REFINED


Locations(1)

CEntre de Recherche et d'Innovation en Audiologie Humaine

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05985473